Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 22.09.2021.

#AntimicrobialResistance
#ClimateChange
#LifeSciences
#AMR
#antibiotics

Startups

@FierceBiotech shared
On Sep 21, 2021
Novartis buys second optogenetics biotech Arctos Medical, with big plans to help patients with all kinds of vision loss @Novartis $NVS https://t.co/tlvBGRQeHa
Open
Novartis doesn't think optogenetics will completely cure blindness—but its new biotech is going to give it a try

Novartis doesn't think optogenetics will completely cure blindness—but its new biotech is going to give it a try

Novartis already bought into optogenetic gene therapy technology last year, but the Swiss Pharma wants more. Enter Arctos Medical, which will now join Novartis with its gene therapy program ...

@IAmBiotech shared
On Sep 20, 2021
“Biotechnology Can Fight #ClimateChange—But Trade Negotiators Need to Act,” writes @DrMichelleBIO via @Newsweek: https://t.co/qyer33YDI8
Open
Biotechnology Can Fight Climate Change—But Trade Negotiators Need to Act | Opinion

Biotechnology Can Fight Climate Change—But Trade Negotiators Need to Act | Opinion

Advances in biotechnology, especially within the agricultural sector, can help us overcome the immense, interconnected challenges of climate change and global hunger.

@MassBio shared
On Sep 16, 2021
As the #LifeSciences continues to drive economic growth in MA & beyond, it's critical that we continue to invest in infrastructure to support the cluster's sustained expansion. Tim Schoen, CEO, @BioMedRealty explores why in today's blog. Read more: https://t.co/Ny26VnWKpE
Open
Purpose-Built Infrastructure Assets for the Life Sciences Industry

Purpose-Built Infrastructure Assets for the Life Sciences Industry

While Washington continues to work on public infrastructure legislation designed to spur economic growth and create jobs, the Boston business community must also do its part to maintain the ...

@ldtimmerman shared
On Sep 21, 2021
The Timmerman Traverse for @LS_Cares recap. Comments from fellow trekkers @vintweeta @ArtKrieg @AlicePomponio @ReidHuber @DaveMelville1 @SamTruex @katherun @JebKeiper @AkikoaCom https://t.co/T0e8UJby7T
Open
A Magical Time in the Presidential Range, Giving Back to Community

A Magical Time in the Presidential Range, Giving Back to Community

The Timmerman Traverse for Life Science Cares was everything I dreamed it would be. Here’s a quick recap: The team of 20 raised $706,000 to fight poverty 51 sponsors participated About 530 ...

@IAmBiotech shared
On Sep 22, 2021
RT @AMRActionFund: We are delighted to announce William Burns’ appointment as AMR Action Fund Board Chair 👏 Mr. Burns brings a lifelong career in the pharmaceutical and life science industry to the Fund, an invaluable experience for his new role: https://t.co/ky9pTf66i1. #AntimicrobialResistance https://t.co/jfbrXFolR5
Open
The AMR Action Fund Appoints Bill Burns as Board Chair

The AMR Action Fund Appoints Bill Burns as Board Chair

The AMR Action Fund Appoints Bill Burns as Board Chair

@Forbes shared
On Sep 15, 2021
RT @giacomotognini: Today's @DutchBros IPO is the largest in Oregon's history to date (beating both $NKE and $COLM) and also brewed the state's newest billionaire: cofounder Travis Boersma, who is now worth an estimated $2.6 billion. Read more about the coffee mogul @forbes: https://t.co/7coPA777iR
Open
Dutch Bros Coffee IPO Brews Oregon’s Newest Billionaire

Dutch Bros Coffee IPO Brews Oregon’s Newest Billionaire

The coffee chain founded by brothers Travis and Dane Boersma in 1992 went public on Wednesday in what is Oregon’s largest IPO to date, making cofounder and executive chairman Travis Boersma ...

@IAmBiotech shared
On Sep 20, 2021
New piece by @DrMichelleBIO and @ForgeThera Chief Scientific Officer Dr. Andrew Tomaras in @sdut: “Antibiotic-resistant superbugs are a ticking time bomb in global health care” #AMR #AntimicrobialResistance #antibiotics https://t.co/4hUC11JiAZ
Open
Opinion: Antibiotic-resistant superbugs are a ticking time bomb in global health care

Opinion: Antibiotic-resistant superbugs are a ticking time bomb in global health care

By 2050, superbugs could kill 10 million people a year.

@ForbesTech shared
On Sep 17, 2021
Record $15 Billion SPAC Merger Just Happened For A Technology You've Never Heard Of https://t.co/nlXj8lk58v https://t.co/Y0tkhMfoXS
Open
Record $15 Billion SPAC Merger Just Happened For A Technology You've Never Heard Of

Record $15 Billion SPAC Merger Just Happened For A Technology You've Never Heard Of

Ginkgo's $15 billion pre-money equity valuation is one of the largest SPAC deals in history. Appropriately, the company plans to trade under the ticker symbols, $DNA

Read more: Startups
weekly 22.09.2021
View archives
Back to home

Subscribe to Biotech Essentials - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Startups.
Privacy Policy

Sign up for the weekly Biotech Essentials - Startups newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy